Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 16801-16850 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04665310
Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant
PHASE4
Active, not recruiting
46 participants
Started: Sep 1, 2018 · Completed: Oct 31, 2025
3 conditions
2 sponsors
0 locations
NCT03847831
Feasibility Study of the Pilot Post-primary Active School Flag (PPASF) Program
NA
Active, not recruiting
9,000 participants
Started: Sep 1, 2018 · Completed: Jun 1, 2030
4 conditions
1 sponsor
1 location
NCT04074824
A Genome-Wide Association Study for Neonatal Diseases
N/A
Active, not recruiting
310 participants
Started: Sep 1, 2018 · Completed: Oct 31, 2026
2 conditions
1 sponsor
1 location
NCT04342078
Vitamin D and Health Outcomes in Preterm Born Population
N/A
Active, not recruiting
87 participants
Started: Sep 1, 2018 · Completed: Dec 31, 2023
6 conditions
1 sponsor
1 location
NCT04321876
Evaluation of a Collaborative Behavioral Health Program Implementation in Primary Care
N/A
Active, not recruiting
778 participants
Started: Sep 1, 2018 · Completed: Sep 1, 2025
1 condition
2 sponsors
1 location
NCT03714633
Stockholm Preterm Interaction-Based Intervention
NA
Active, not recruiting
130 participants
Started: Sep 1, 2018 · Completed: Dec 31, 2024
1 condition
7 sponsors
5 locations
NCT03560622
Functional Neuroimaging Feedback for Focused Ultrasound Thalamotomy
NA
Active, not recruiting
30 participants
Started: Sep 1, 2018 · Completed: Dec 31, 2021
1 condition
3 sponsors
1 location
NCT03677947
Inference-Based Cognitive Therapy Versus Exposure and Response Prevention for Obsessive-Compulsive Disorder
NA
Active, not recruiting
150 participants
Started: Sep 1, 2018 · Completed: Mar 31, 2025
2 conditions
2 sponsors
1 location
NCT03560934
Tetrahydrocannabinol (THC) and Sleep
EARLY_PHASE1
Active, not recruiting
18 participants
Started: Sep 1, 2018 · Completed: Apr 30, 2025
4 conditions
1 sponsor
1 location
NCT04389879
CAD/CAM Fixed Retainers vs. Conventional Multistranded Fixed Retainers in Orthodontic Patients. Comparison of Stability, Retainer Failure Rate, Adverse Effects, Cost-effectiveness, and Patient Satisfaction. A Randomized Controlled Clinical Trial
NA
Active, not recruiting
126 participants
Started: Sep 1, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT03107871
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants
PHASE2
Active, not recruiting
52 participants
Started: Aug 31, 2018 · Completed: Jul 31, 2024
5 conditions
3 sponsors
30 locations
NCT03523442
A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer
PHASE1
Active, not recruiting
19 participants
Started: Aug 31, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
4 locations
NCT03696030
HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases
PHASE1
Active, not recruiting
24 participants
Started: Aug 31, 2018 · Completed: Feb 19, 2026
5 conditions
3 sponsors
1 location
NCT03626688
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
PHASE3
Active, not recruiting
1,000 participants
Started: Aug 30, 2018 · Completed: Dec 31, 2025
11 conditions
1 sponsor
209 locations
NCT03636438
Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency
N/A
Active, not recruiting
11 participants
Started: Aug 30, 2018 · Completed: Dec 31, 2029
1 condition
1 sponsor
9 locations
NCT03463057
The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL
PHASE2
Active, not recruiting
109 participants
Started: Aug 30, 2018 · Completed: Jan 31, 2027
2 conditions
1 sponsor
32 locations
NCT03612648
Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma
NA
Active, not recruiting
77 participants
Started: Aug 30, 2018 · Completed: Mar 22, 2026
2 conditions
1 sponsor
1 location
NCT03361735
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
PHASE2
Active, not recruiting
25 participants
Started: Aug 29, 2018 · Completed: Feb 4, 2026
1 condition
1 sponsor
1 location
NCT03611868
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
230 participants
Started: Aug 29, 2018 · Completed: Dec 30, 2025
8 conditions
2 sponsors
21 locations
NCT03515798
Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer
PHASE2
Active, not recruiting
52 participants
Started: Aug 29, 2018 · Completed: Aug 22, 2027
1 condition
3 sponsors
12 locations
NCT03424343
Longitudinal Identity Study of Childhood Cancer Survivors
N/A
Active, not recruiting
126 participants
Started: Aug 28, 2018 · Completed: Dec 31, 2024
1 condition
3 sponsors
1 location
NCT03649958
Neurotechnology Following Traumatic Brain Injury
NA
Active, not recruiting
80 participants
Started: Aug 28, 2018 · Completed: Jul 1, 2024
4 conditions
3 sponsors
2 locations
NCT03948035
Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
PHASE3
Active, not recruiting
576 participants
Started: Aug 28, 2018 · Completed: Aug 31, 2029
1 condition
3 sponsors
56 locations
NCT03595098
Treatment Effects of Family Based Cognitive Therapy in Children and Adolescents With Obsessive Compulsive Disorder
NA
Active, not recruiting
128 participants
Started: Aug 28, 2018 · Completed: Dec 31, 2027
2 conditions
3 sponsors
1 location
NCT03398135
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
PHASE3
Active, not recruiting
1,242 participants
Started: Aug 28, 2018 · Completed: Feb 28, 2029
1 condition
1 sponsor
426 locations
NCT03521596
Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS
N/A
Active, not recruiting
300 participants
Started: Aug 28, 2018 · Completed: Oct 31, 2025
1 condition
1 sponsor
14 locations
NCT03457194
Optimising Protection for Pregnant Women and Infants With Maternal Vaccination
N/A
Active, not recruiting
73 participants
Started: Aug 28, 2018 · Completed: Mar 1, 2024
1 condition
2 sponsors
1 location
NCT03726554
Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty
NA
Active, not recruiting
102 participants
Started: Aug 28, 2018 · Completed: Feb 28, 2030
5 conditions
1 sponsor
6 locations
NCT05250154
Rheumatic Heart Disease Research and Screening in Nepal: A Feasibility Study
N/A
Active, not recruiting
2,438 participants
Started: Aug 27, 2018 · Completed: May 1, 2040
1 condition
3 sponsors
1 location
NCT03457948
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases
PHASE2
Active, not recruiting
32 participants
Started: Aug 27, 2018 · Completed: May 31, 2026
2 conditions
3 sponsors
1 location
NCT03784066
Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity
PHASE1/PHASE2
Active, not recruiting
21 participants
Started: Aug 27, 2018 · Completed: Mar 24, 2026
1 condition
4 sponsors
1 location
NCT03600441
Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
PHASE2
Active, not recruiting
139 participants
Started: Aug 27, 2018 · Completed: Dec 31, 2029
1 condition
1 sponsor
15 locations
NCT03600883
A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)
PHASE1/PHASE2
Active, not recruiting
713 participants
Started: Aug 27, 2018 · Completed: Jan 31, 2026
1 condition
1 sponsor
133 locations
NCT03531255
Pegcetacoplan Long Term Safety and Efficacy Extension Study
PHASE3
Active, not recruiting
160 participants
Started: Aug 27, 2018 · Completed: Jun 30, 2025
1 condition
1 sponsor
62 locations
NCT03673007
Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1
NA
Active, not recruiting
4,633 participants
Started: Aug 26, 2018 · Completed: Dec 31, 2028
1 condition
2 sponsors
9 locations
NCT03687593
Safety and Performance Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts
N/A
Active, not recruiting
126 participants
Started: Aug 26, 2018 · Completed: Apr 1, 2028
1 condition
1 sponsor
4 locations
NCT03535350
Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
PHASE1
Active, not recruiting
36 participants
Started: Aug 24, 2018 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT03391973
Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)
PHASE2
Active, not recruiting
26 participants
Started: Aug 24, 2018 · Completed: Dec 30, 2025
1 condition
2 sponsors
3 locations
NCT03609060
Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)
PHASE2
Active, not recruiting
120 participants
Started: Aug 24, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
25 locations
NCT03556085
Venous Sinus Stenting With the River Stent in IIH
NA
Active, not recruiting
39 participants
Started: Aug 24, 2018 · Completed: Nov 1, 2026
1 condition
1 sponsor
6 locations
NCT03603912
Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)
PHASE4
Active, not recruiting
175 participants
Started: Aug 24, 2018 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT03581942
Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)
PHASE1/PHASE2
Active, not recruiting
18 participants
Started: Aug 23, 2018 · Completed: Jul 31, 2026
1 condition
1 sponsor
7 locations
NCT03485547
Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
PHASE1
Active, not recruiting
5 participants
Started: Aug 23, 2018 · Completed: Feb 17, 2026
1 condition
2 sponsors
2 locations
NCT03527472
Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
PHASE2
Active, not recruiting
111 participants
Started: Aug 23, 2018 · Completed: Dec 31, 2025
1 condition
4 sponsors
3 locations
NCT03533517
Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction
NA
Active, not recruiting
22 participants
Started: Aug 23, 2018 · Completed: Feb 28, 2026
2 conditions
1 sponsor
18 locations
NCT03606161
Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors
NA
Active, not recruiting
32 participants
Started: Aug 23, 2018 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT03880383
BRIGHT Coaching Program for Families
NA
Active, not recruiting
306 participants
Started: Aug 23, 2018 · Completed: Mar 31, 2025
7 conditions
3 sponsors
4 locations
NCT03642639
A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms
NA
Active, not recruiting
850 participants
Started: Aug 23, 2018 · Completed: Sep 30, 2025
1 condition
1 sponsor
3 locations
NCT03374657
A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa
PHASE1/PHASE2
Active, not recruiting
12 participants
Started: Aug 22, 2018 · Completed: May 11, 2026
1 condition
1 sponsor
1 location
NCT03633799
Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS
PHASE3
Active, not recruiting
1,620 participants
Started: Aug 22, 2018 · Completed: Sep 22, 2027
1 condition
2 sponsors
41 locations
Previous
1
More pages
334
335
336
337
338
339
340
More pages
431
Next